These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 12829739)

  • 1. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.
    Potterf SB; Furumura M; Sviderskaya EV; Santis C; Bennett DC; Hearing VJ
    Exp Cell Res; 1998 Oct; 244(1):319-26. PubMed ID: 9770375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2.
    Manga P; Boissy RE; Pifko-Hirst S; Zhou BK; Orlow SJ
    Exp Eye Res; 2001 Jun; 72(6):695-710. PubMed ID: 11384158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression.
    Ni-Komatsu L; Orlow SJ
    Exp Eye Res; 2006 Mar; 82(3):519-28. PubMed ID: 16199032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4.
    Kondo T; Namiki T; Coelho SG; Valencia JC; Hearing VJ
    J Dermatol Sci; 2015 Jan; 77(1):21-7. PubMed ID: 25530116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine.
    Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ
    Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation.
    Hirobe T; Ishikawa A
    J Dermatol Sci; 2015 Dec; 80(3):203-11. PubMed ID: 26475433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular and molecular features of mammalian pigmentation--tyrosinase and TRP].
    Camacho-Hübner A; Beermann F
    Pathol Biol (Paris); 2000 Jul; 48(6):577-83. PubMed ID: 10965538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oculocutaneous albinism type IV gene Matp is a new marker of pigment cell precursors during mouse embryonic development.
    Baxter LL; Pavan WJ
    Mech Dev; 2002 Aug; 116(1-2):209-12. PubMed ID: 12128226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess tyrosine rescues the reduced activity of proliferation and differentiation of cultured recessive yellow melanocytes derived from neonatal mouse epidermis.
    Hirobe T; Abe H; Wakamatsu K; Ito S; Kawa Y; Soma Y; Mizoguchi M
    Eur J Cell Biol; 2007 Jun; 86(6):315-30. PubMed ID: 17532540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of melanosome morphology associated with the differentiation of epidermal melanocytes in slaty mice.
    Hirobe T; Abe H
    Anat Rec (Hoboken); 2007 Aug; 290(8):981-93. PubMed ID: 17516460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of mutation in dopachrome tautomerase on melanosome maturation and anti-oxidative potential in cultured melanocytes].
    Wan J; Liu XM; Lei TC; Xu SZ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1707-10. PubMed ID: 19957532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.